Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RACHEL BETTHAUSER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1295389914
CMS profile
10929420
Location
MILWAUKEE, WI

General Payments · PY2021–2024

$888.92

  • Reported across 38 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$501.26

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $501.26 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $134.05 8
PY2022 $123.77 7
PY2023 $129.84 7
PY2024 $501.26 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $26.07 10/07/2024 Food and Beverage Undisputed 01/23/2026 1142298257 CMS
ABIOMED $20.11 12/02/2024 Food and Beverage Undisputed 01/23/2026 1142298405 CMS
AstraZeneca Pharmaceuticals LP $16.08 05/23/2024 Food and Beverage Undisputed 01/23/2026 1105829521 CMS
AstraZeneca Pharmaceuticals LP $26.87 09/01/2024 Food and Beverage Undisputed 01/23/2026 1104271613 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.53 11/04/2024 Food and Beverage Undisputed 01/23/2026 1117951812 CMS
Merck Sharp & Dohme LLC $17.82 11/20/2024 Food and Beverage Undisputed 01/23/2026 1141830308 CMS
Novartis Pharmaceuticals Corporation $30.79 02/06/2024 Food and Beverage Undisputed 01/23/2026 1086623579 CMS
Novartis Pharmaceuticals Corporation $23.37 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086623587 CMS
Novartis Pharmaceuticals Corporation $32.80 08/30/2024 Food and Beverage Undisputed 01/23/2026 1086623589 CMS
Novo Nordisk Inc $20.89 04/24/2024 Food and Beverage Undisputed 01/23/2026 1100459676 CMS
Novo Nordisk Inc $21.07 06/06/2024 Food and Beverage Undisputed 01/23/2026 1100340060 CMS
Novo Nordisk Inc $20.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 1100501083 CMS
Novo Nordisk Inc $66.82 11/07/2024 Food and Beverage Undisputed 01/23/2026 1100562031 CMS
Paragonix Technologies, Inc. $142.92 04/11/2024 Food and Beverage Undisputed 01/23/2026 1101026854 CMS
Paragonix Technologies, Inc. $1.86 04/11/2024 Food and Beverage Undisputed 01/23/2026 1101026856 CMS
Paragonix Technologies, Inc. $15.26 04/11/2024 Food and Beverage Undisputed 01/23/2026 1101026858 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.